Depression in Patients With Lung Cancer: Prevalence and Risk Factors Derived From Quality-of-Life Data

American Society of Clinical Oncology (ASCO) - Tập 18 Số 4 - Trang 893-893 - 2000
Penelope Hopwood1, Richard Stephens1
1From The Cancer Research Campaign Psychological Medicine GroupChristie Hospital National Health Service Trust, Withington, Manchester; Cancer Division, Medical Research Council Clinical Trials Unit, London, United Kingdom.

Tóm tắt

PURPOSE: To evaluate self-reported depression rates in patients with inoperable lung cancer and to explore demographic, clinical, and quality-of-life (QOL) factors associated with depression and thus identify patients at risk. PATIENTS AND METHODS: Nine hundred eighty-seven patients from three palliative treatment trials conducted by the Medical Research Council Lung Cancer Working Party formed the study sample. 526 patients (53%) had poor prognosis small-cell lung cancer (SCLC) and 461 patients (47%) had good prognosis non–small-cell lung cancer (NSCLC). Hospital Anxiety and Depression Scale data and QOL items from the Rotterdam Symptom Checklist were analyzed, together with relevant demographic and clinical factors. RESULTS: Depression was self-rated in 322 patients (33%) before treatment and persisted in more than 50% of patients. SCLC patients had a three-fold greater prevalence of case depression than those with NSCLC (25% v 9%; P < .0001). An increased rate for women was found for good performance status (PS) patients (PS of 0 or 1) but the sex difference reduced for poor PS patients (PS of 3 or 4) because of increased depression rates for men (χ2 for trend, P < .0001). Multivariate analysis showed that functional impairment was the most important risk factor; depression increased by 41% for each increment on the impairment scale. Pretreatment physical symptom burden, fatigue, and clinician-rated PS were also independent predictors, but cell type was not. CONCLUSION: Depression is common and persistent in lung cancer patients, especially those with more severe symptoms or functional limitations. Psychologic screening and appropriate intervention is an essential part of palliative care.

Từ khóa


Tài liệu tham khảo

10.1177/026921639701100201

Tiernan E: Depression in terminally ill cancer patients. J Ir Med Assoc 91:47,1998-48,

10.1136/jech.52.3.203

10.1111/j.1532-5415.1989.tb01249.x

10.2190/M1F5-F40P-C4KD-YPA3

10.1016/0163-8343(83)90001-4

10.1016/S0140-6736(89)91551-1

10.1007/s005200050142

Harrison J, Haddad P, Maguire P: The impact of cancer on key relatives: A comparison of relative and patient concerns. Eur J Cancer 31A:1736,1995-1740,

10.1016/0277-9536(94)00249-S

10.1038/bjc.1994.393

Hopwood P: The quality of life: Clinical judgement versus self-report measures. Cancer Topics 8:1122,1992-1124,

10.1200/JCO.1998.16.4.1594

Valente SM, Saunders JM: Evaluating depression among patients with cancer. Cancer Pract 2:65,1994-71,

10.1097/00006842-197707000-00007

10.1001/jama.1983.03330300035030

Massie MJ, Holland JC: Depression and the cancer patient. J Clin Psychiatry 75:12,1990-17,

10.1016/0167-8140(93)90073-H

10.1111/j.1600-0447.1983.tb09716.x

10.1016/S0959-8049(97)00054-3

10.1038/bjc.1990.434

10.1038/bjc.1995.124

10.1192/bjp.169.2.236

10.1002/(SICI)1099-1611(199811/12)7:6<483::AID-PON326>3.0.CO;2-M

10.1038/bjc.1991.304

10.1038/bjc.1996.71

10.1016/S0140-6736(96)02005-3

10.1016/S0936-6555(96)80041-0

10.1038/bjc.1991.305

Stephens RJ, Hopwood P: Constructing a clinically useful functional impairment scale from the Rotterdam Symptom Checklist (RSCL). Lung Cancer 18:208,1997 (suppl 1) (abstr 805

10.1093/jnci/85.5.365

10.1002/(SICI)1097-0142(19960901)78:5<1131::AID-CNCR26>3.0.CO;2-2

10.1016/0163-8343(93)90099-A

10.1164/ajrccm/140.6.1538

10.1097/00005053-199502000-00005

10.1192/bjp.165.5.593

10.1002/(SICI)1099-1611(199811/12)7:6<502::AID-PON336>3.0.CO;2-T

10.1001/archpsyc.1995.03950140007002

Holland JC: Managing depression in the patient with cancer. Cancer 37:366,1987-371,

Schwenk TL: Cancer and depression. Oncology 25:505,1998-513,

Thông tin
Thông tin xuất bản

American Society of Clinical Oncology (ASCO)

Tập 18 Số 4

893-893

Thông tin tác giả